[1]
Maserati E,Panarello C,Morerio C,Valli R,Pressato B,Patitucci F,Tassano E,Di Cesare-Merlone A,Cugno C,Balduini CL,Lo Curto F,Dufour C,Locatelli F,Pasquali F, Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica. 2008 Aug; [PubMed PMID: 18519517]
[2]
Khincha PP,Savage SA, Neonatal manifestations of inherited bone marrow failure syndromes. Seminars in fetal [PubMed PMID: 26724991]
[3]
Al-Qahtani FS, Congenital amegakaryocytic thrombocytopenia: a brief review of the literature. Clinical medicine insights. Pathology. 2010 Jun 4; [PubMed PMID: 21151552]
[4]
Ballmaier M,Germeshausen M, Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Seminars in thrombosis and hemostasis. 2011 Sep; [PubMed PMID: 22102270]
[5]
Simkins A,Maiti A,Short NJ,Jain N,Popat U,Patel KP,Oo TH, Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematology/oncology and stem cell therapy. 2019 Jun; [PubMed PMID: 29409729]
[7]
Chaudhary UB,Eberwine SF,Hege KM, Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course. American journal of hematology. 2004 Mar; [PubMed PMID: 14978695]
[9]
Geddis AE, Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Hematology/oncology clinics of North America. 2009 Apr; [PubMed PMID: 19327586]
[10]
Azuno Y,Yaga K, Successful cyclosporin A therapy for acquired amegakaryocytic thrombocytopenic purpura. American journal of hematology. 2002 Apr; [PubMed PMID: 11921030]
[11]
Varghese LN,Defour JP,Pecquet C,Constantinescu SN, The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin. Frontiers in endocrinology. 2017; [PubMed PMID: 28408900]
[12]
Mulroy E,Gleeson S,Chiruka S, Danazol: an effective option in acquired amegakaryocytic thrombocytopaenic purpura. Case reports in hematology. 2015; [PubMed PMID: 25945269]
[13]
Evans DI, Immune amegakaryocytic thrombocytopenia of the newborn: association with anti-HLA-A2. Journal of clinical pathology. 1987 Mar; [PubMed PMID: 3494047]
[14]
Khan F,Shehna A,Mukundan L, Mononeuritis multiplex in acquired amegakaryocytic thrombocytopenia. Journal of neurosciences in rural practice. 2015 Oct-Dec; [PubMed PMID: 26752909]
[15]
Ichikawa T,Shimojima Y,Otuki T,Ueno KI,Kishida D,Sekijima Y, Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine. Internal medicine (Tokyo, Japan). 2019 Dec 1; [PubMed PMID: 31391399]
[16]
Manoharan A,Williams NT,Sparrow R, Acquired amegakaryocytic thrombocytopenia: report of a case and review of literature. The Quarterly journal of medicine. 1989 Mar; [PubMed PMID: 2690174]
[17]
Dahal S,Sharma E,Dahal S,Shrestha B,Bhattarai B, Acquired Amegakaryocytic Thrombocytopenia and Pure Red Cell Aplasia in Thymoma. Case reports in hematology. 2018; [PubMed PMID: 29713553]
[18]
Agarwal N,Spahr JE,Werner TL,Newton DL,Rodgers GM, Acquired amegakaryocytic thrombocytopenic purpura. American journal of hematology. 2006 Feb; [PubMed PMID: 16432869]
[19]
Ergas D,Tsimanis A,Shtalrid M,Duskin C,Berrebi A, T-gamma large granular lymphocyte leukemia associated with amegakaryocytic thrombocytopenic purpura, Sjögren's syndrome, and polyglandular autoimmune syndrome type II, with subsequent development of pure red cell aplasia. American journal of hematology. 2002 Feb; [PubMed PMID: 11835350]
[20]
Savoia A,Dufour C,Locatelli F,Noris P,Ambaglio C,Rosti V,Zecca M,Ferrari S,di Bari F,Corcione A,Di Stazio M,Seri M,Balduini CL, Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Haematologica. 2007 Sep; [PubMed PMID: 17666371]
[21]
Novotný JP,Köhler B,Max R,Egerer G, Acquired Amegakaryocytic Thrombocytopenic Purpura Progressing into Aplastic Anemia. Prague medical report. 2017; [PubMed PMID: 29324222]
[24]
Hirata S,Takayama N,Jono-Ohnishi R,Endo H,Nakamura S,Dohda T,Nishi M,Hamazaki Y,Ishii E,Kaneko S,Otsu M,Nakauchi H,Kunishima S,Eto K, Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling. The Journal of clinical investigation. 2013 Sep; [PubMed PMID: 23908116]
[25]
Ok Bozkaya İ,Yaralı N,Işık P,Ünsal Saç R,Tavil B,Tunç B, Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene. Turkish journal of haematology : official journal of Turkish Society of Haematology. 2015 Jun; [PubMed PMID: 26316487]
[26]
Ihara K,Ishii E,Eguchi M,Takada H,Suminoe A,Good RA,Hara T, Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proceedings of the National Academy of Sciences of the United States of America. 1999 Mar 16; [PubMed PMID: 10077649]
[27]
Pecci A,Ragab I,Bozzi V,De Rocco D,Barozzi S,Giangregorio T,Ali H,Melazzini F,Sallam M,Alfano C,Pastore A,Balduini CL,Savoia A, Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim. EMBO molecular medicine. 2018 Jan; [PubMed PMID: 29191945]
[28]
Germeshausen M,Ancliff P,Estrada J,Metzler M,Ponstingl E,Rütschle H,Schwabe D,Scott RH,Unal S,Wawer A,Zeller B,Ballmaier M, MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood advances. 2018 Mar 27; [PubMed PMID: 29540340]
[29]
Lonial S,Bilodeau PA,Langston AA,Lewis C,Mossavi-Sai S,Holden JT,Waller EK, Acquired amegakaryocytic thrombocytopenia treated with allogeneic BMT: a case report and review of the literature. Bone marrow transplantation. 1999 Dec; [PubMed PMID: 10627644]
[30]
Nishino S,Kodaka T,Sawada Y,Goka T,Gotoh Y,Tsunemine H,Takahashi T, Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia. Journal of clinical and experimental hematopathology : JCEH. 2018 Dec 13; [PubMed PMID: 30416171]
[31]
Katsumata Y,Suzuki T,Kuwana M,Hattori Y,Akizuki S,Sugiura H,Matsuoka Y, Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis and rheumatism. 2003 Jun; [PubMed PMID: 12794833]
[32]
Ichimata S,Kobayashi M,Honda K,Shibata S,Matsumoto A,Kanno H, Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection. World journal of gastroenterology. 2017 Sep 21; [PubMed PMID: 29085203]
[33]
Germeshausen M,Ballmaier M, CAMT-MPL: Congenital Amegakaryocytic Thrombocytopenia caused by {i}MPL{/i} mutations - Heterogeneity of a monogenic disorder - Comprehensive analysis of 56 patients. Haematologica. 2020 Jul 23; [PubMed PMID: 32703794]
[34]
Obi EI,Osegi N,Etu-Efeotor TP,Pughikumo OC,Toluhi H,Makinde O, Massive hemoperitoneum from hemorrhagic corpus luteum in a patient with acquired amegakaryocytic thrombocytopenic purpura. Clinical case reports. 2020 Apr; [PubMed PMID: 32274044]
[35]
Ballmaier M,Holter W,Germeshausen M, Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias. Haematologica. 2015 Sep; [PubMed PMID: 25911549]
[36]
Cleyrat C,Girard R,Choi EH,Jeziorski É,Lavabre-Bertrand T,Hermouet S,Carillo S,Wilson BS, Gene editing rescue of a novel {i}MPL{/i} mutant associated with congenital amegakaryocytic thrombocytopenia. Blood advances. 2017 Sep 26; [PubMed PMID: 29296828]
[37]
Fox NE,Lim J,Chen R,Geddis AE, F104S c-Mpl responds to a transmembrane domain-binding thrombopoietin receptor agonist: proof of concept that selected receptor mutations in congenital amegakaryocytic thrombocytopenia can be stimulated with alternative thrombopoietic agents. Experimental hematology. 2010 May; [PubMed PMID: 20188141]
[38]
Dragani M,Andreani G,Familiari U,Marci V,Rege-Cambrin G, Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory. Clinical case reports. 2020 Apr; [PubMed PMID: 32274018]
[39]
Katai M,Aizawa T,Ohara N,Hiramatsu K,Hashizume K,Yamada T,Kitano K,Saito H,Shinoda T,Wakata S, Acquired amegakaryocytic thrombocytopenic purpura with humoral inhibitory factor for megakaryocyte colony formation. Internal medicine (Tokyo, Japan). 1994 Mar; [PubMed PMID: 8061390]
[40]
Gupta L,Gupta V,Pani KC,Mittal N,Agarwal V, Successful use of azathioprine in glucocorticoid refractory immune amegakaryocytic thrombocytopenia of lupus. Reumatologia clinica. 2020 May - Jun; [PubMed PMID: 29678667]